Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print March 30, 2007, 10.1097/PSY.0b013e3180313a45
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiecolt-Glaser, J. K.
Right arrow Articles by Glaser, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiecolt-Glaser, J. K.
Right arrow Articles by Glaser, R.
Related Collections
Right arrow Immunology
Right arrow Depression
Psychosomatic Medicine 69:217-224 (2007)
© 2007 American Psychosomatic Society


ORIGINAL ARTICLES

Depressive Symptoms, omega-6:omega-3 Fatty Acids, and Inflammation in Older Adults

Janice K. Kiecolt-Glaser, PhD, Martha A. Belury, PhD, Kyle Porter, MAS, David Q. Beversdorf, MD, Stanley Lemeshow, PhD and Ronald Glaser, PhD

From the Departments of Psychiatry (J.K.K.-G.), Human Nutrition (M.A.B.), Ohio State University Center for Biostatistics (K.P., S.L.), Neurology (D.Q.B.), Ohio State University School of Public Health (S.L.), Molecular Virology, Immunology, and Medical Genetics (R.G.), Ohio State Institute for Behavioral Medicine Research (J.K.K.-G., S.L., R.G.); Ohio State University, Columbus, Ohio.

Address correspondence and reprint requests to Janice K. Kiecolt-Glaser, Department of Psychiatry, Ohio State University College of Medicine, 1670 Upham Drive, Columbus, OH 43210. E-mail: Kiecolt-Glaser.1{at}osu.edu

Objective: To address how interactions between polyunsaturated fatty acid (PUFA) levels and depressive symptoms were related to proinflammatory cytokine synthesis. Depression and stress promote proinflammatory cytokine production. Dietary intakes of omega-3 (n-3) and omega-6 (n-6) PUFAs also influence inflammation; high n-6:n-3 ratios enhance proinflammatory cytokine production, although n-3 has anti-inflammatory properties.

Methods: Blood samples from 43 older adults (mean age = 66.67 years, SD = 10.09) provided data on PUFAs and tumor necrosis factor (TNF)-{alpha}, interleukin (IL)-6, and IL-6 soluble receptor (sIL-6r). Depressive symptoms were assessed by the Center for Epidemiological Studies Depression Scale.

Results: Depressive symptoms and n-6:n-3 ratios worked together to enhance proinflammatory cytokines beyond the contribution provided by either variable alone, with substantial variance explained by their interaction: 13% for IL-6 and 31% for TNF-{alpha}, whereas full models accounted for 18% and 40%, respectively. Although predicted cytokine levels were consistent across n-6:n-3 ratios with low depressive symptoms, higher n-6:n-3 ratios were associated with progressively elevated TNF-{alpha} and IL-6 levels as depressive symptoms increased. Higher levels of sIL-6r were associated with higher n-6:n-3 ratios. Six individuals who met the criteria for major depressive disorder had higher n-6:n-3 ratios and TNF-{alpha}, IL-6, and sIL-6r levels than those who did not meet the criteria; excluding these six individuals reduced the variance explained by the depressive symptoms and n-6:n-3 ratio interaction.

Conclusions: Diets with high n-6:n-3 PUFA ratios may enhance the risk for both depression and inflammatory diseases.

Key Words: depression • proinflammatory cytokines • omega-3 • psychoneuroimmunology

Abbreviations: AA = arachidonic acid; BMI = body mass index; CES-D = Center for Epidemiological Studies Depression Scale; DHA = docosahexanoic acid; EPA = eicosapentaenoic acid; IL-6 = interleukin-6; sIL-6r = IL-6 soluble receptor; n-3 = omega-3; n-6 = omega-6; NF-{kappa}B = nuclear factor kappa B; PSQI = Pittsburgh Sleep Quality Index; PUFA = polyunsaturated fatty acid; TNF-{alpha} = tumor necrosis factor-{alpha}.




This article has been cited by other articles:


Home page
JAMAHome page
R. M. Carney, K. E. Freedland, E. H. Rubin, M. W. Rich, B. C. Steinmeyer, and W. S. Harris
Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease: A Randomized Controlled Trial
JAMA, October 21, 2009; 302(15): 1651 - 1657.
[Abstract] [Full Text] [PDF]


Home page
Perspectives on Psychological ScienceHome page
J. K. Kiecolt-Glaser
Psychoneuroimmunology: Psychology's Gateway to the Biomedical Future
Perspectives on Psychological Science, July 1, 2009; 4(4): 367 - 369.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. B. Howren, D. M. Lamkin, and J. Suls
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
Psychosom Med, February 1, 2009; 71(2): 171 - 186.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. A. Amin, R. A. Menon, K. J. Reid, W. S. Harris, and J. A. Spertus
Acute Coronary Syndrome Patients With Depression Have Low Blood Cell Membrane Omega-3 Fatty Acid Levels
Psychosom Med, October 1, 2008; 70(8): 856 - 862.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Psychosomatic Society